chr5-180911602-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001040462.3(BTNL8):c.661G>A(p.Val221Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000261 in 1,611,542 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001040462.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BTNL8 | NM_001040462.3 | c.661G>A | p.Val221Ile | missense_variant | 3/8 | ENST00000340184.9 | NP_001035552.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BTNL8 | ENST00000340184.9 | c.661G>A | p.Val221Ile | missense_variant | 3/8 | 1 | NM_001040462.3 | ENSP00000342197 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152136Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000173 AC: 43AN: 247858Hom.: 0 AF XY: 0.000142 AC XY: 19AN XY: 134000
GnomAD4 exome AF: 0.000275 AC: 401AN: 1459406Hom.: 0 Cov.: 33 AF XY: 0.000259 AC XY: 188AN XY: 725502
GnomAD4 genome AF: 0.000131 AC: 20AN: 152136Hom.: 0 Cov.: 32 AF XY: 0.000161 AC XY: 12AN XY: 74330
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 08, 2022 | The c.661G>A (p.V221I) alteration is located in exon 3 (coding exon 3) of the BTNL8 gene. This alteration results from a G to A substitution at nucleotide position 661, causing the valine (V) at amino acid position 221 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at